کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
3391563 1221059 2012 7 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Treatment options and strategies for antibody mediated rejection after renal transplantation
موضوعات مرتبط
علوم زیستی و بیوفناوری ایمنی شناسی و میکروب شناسی ایمونولوژی
پیش نمایش صفحه اول مقاله
Treatment options and strategies for antibody mediated rejection after renal transplantation
چکیده انگلیسی

Antibody mediated rejection is a significant clinical problem encountered in a subset of renal transplant recipients. This type of rejection has a variable pathogenesis from the presence of donor specific antibodies with no overt disease to immediate hyperacute rejection and many variations between. Antibody mediated rejection is more common in human leukocyte antigen sensitized patients. In general, transplant graft survival after antibody mediated rejection is jeopardized, with less than 50% graft survival 5 years after this diagnosis. A variety of agents have been utilized singly and in combinations to treat antibody mediated rejection with differing results and significant research efforts are being placed on developing new targets for intervention. These same agents have been used in desensitization protocols with some success. In this review, we describe the biology of antibody mediated rejection, review the available agents to treat this form of rejection, and highlight areas of ongoing and future research into this difficult clinical problem.


► Antibody mediated rejection is a significant clinical problem after renal transplant.
► We review the biological basis and pathways of antibody mediated rejection.
► We review available treatments and future directions for therapy.
► We review clinical trials results dealing with antibody mediated rejection.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Seminars in Immunology - Volume 24, Issue 2, April 2012, Pages 136–142
نویسندگان
, ,